Literature DB >> 9920005

Restenosis after percutaneous transluminal coronary angioplasty in patients with non-insulin-dependent diabetes mellitus (NIDDM).

Y Asakura1, M Suzuki, H Nonogi, K Haze, A Sato, H Inada, Y Okuda, K Yamashita, Y Harano.   

Abstract

BACKGROUND: The effect of glycemic control on the incidence of restenosis after percutaneous transluminal coronary angioplasty (PTCA) in non-insulin-dependent diabetes mellitus (NIDDM) has not been well analysed.
METHODS: Out of 1282 consecutive patients who had undergone elective and successful PTCA over 8 years, 86 known to have NIDDM and 117 non-diabetic cases were analysed for restenosis following PTCA. Definition of restenosis is an increase from 50% to 75% diameter stenosis at the same lesion within 1 year after angioplasty. Those with familial hypercholesterolemia, renal failure, unstable angina pectoris, bypass graft surgery within 1 month were excluded. Blood pressure, body mass index, history of smoking, fasting blood glucose, post-prandial glucose, HbA1c, cholesterol, triglycerides, number of stenotic vessels, restenosis rate were studied - 6 months before PTCA and 1, 3, 6 and 12 months after PTCA.
RESULTS: The frequency of restenosis within 1 year of PTCA was significantly greater in poorly controlled NIDDM (75%) than in well or moderately controlled NIDDM (30-40%) or non-diabetic subjects (33%). Multivariate analysis showed that the degree of control of diabetes was significantly correlated with restenosis.
CONCLUSION: Restenosis following elective and successive PTCA was significantly more frequent in poorly controlled NIDDM compared with moderately or well-controlled NIDDM or non-diabetic subjects. Multivariate analysis also showed the significant correlation between restenosis and glycemic control. These findings indicate that control of diabetes plays an important role in reducing restenosis after PTCA.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9920005

Source DB:  PubMed          Journal:  J Cardiovasc Risk        ISSN: 1350-6277


  4 in total

Review 1.  Peroxisome proliferator activated receptor gamma: a potential therapeutic target in the management of ischaemic heart disease.

Authors:  J S Sidhu; J C Kaski
Journal:  Heart       Date:  2001-09       Impact factor: 5.994

2.  Influence of a history of smoking on short term (six month) clinical and angiographic outcome after successful coronary angioplasty.

Authors:  A G Violaris; A Thury; E Regar; R Melkert; P W Serruys
Journal:  Heart       Date:  2000-09       Impact factor: 5.994

3.  In-hospital daily insulin dose predicts long-term adverse outcome in patients with diabetes with ST-elevation myocardial infarction treated with successful primary percutaneous angioplasty.

Authors:  Tomasz Jeżewski; Jan Z Peruga; Jarosław D Kasprzak; Tomasz Bendinger; Michal Plewka; Jarosław Drożdż; Józef Drzewoski; Maria Krzeminska-Pakula
Journal:  Arch Med Sci       Date:  2014-10-23       Impact factor: 3.318

4.  The Effects of Glucose Lowering Agents on the Secondary Prevention of Coronary Artery Disease in Patients with Type 2 Diabetes.

Authors:  Inha Jung; Hyemi Kwon; Se Eun Park; Kyung-Do Han; Yong-Gyu Park; Eun-Jung Rhee; Won-Young Lee
Journal:  Endocrinol Metab (Seoul)       Date:  2021-10-14
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.